The FDA’s decision was based largely on results from a clinical trial that included more than 3,700 heart failure patients with a left ventricular ejection fraction of 40% or less.

Researchers tracked data from more than 49,000 patients who underwent LAAO from January 2016 to June 2019.

Cerebrovascular accidents following PCI appear to be more common when the patient has a history of recent marijuana use. 

Ablation was associated with a 67% reduction in all-cause hospitalizations compared to medication alone. 

“Our study demonstrates that a centrally guided and well-designed healthcare policy may have a real and substantial impact on a patient’s prognosis over a relatively short period of time,” researchers said.

For patients over the age of 65, the stroke risk climbs all the way to 54%. Researchers emphasized how important it is to begin treatment as early as possible. 

The team hopes its findings, published in the European Heart Journal, will help more people consider how their daily lives can affect their health. 

Heart transplant recipients reap significant benefits from a third dose of a COVID-19 vaccine.